These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35240933)

  • 1. Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
    Absalon J; Simon R; Radley D; Giardina PC; Koury K; Jansen KU; Anderson AS
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037350. PubMed ID: 35240933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
    Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
    Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
    Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
    Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
    Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
    Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
    Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
    Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
    Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
    Verani JR; McGee L; Schrag SJ;
    MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do we need a different approach to GBS screening?].
    Szymusik I; Kosińska-Kaczyińska K; Pietrzak B; Wielgoś M
    Ginekol Pol; 2014 Jun; 85(6):456-60. PubMed ID: 25029812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
    Dzanibe S; Madhi SA
    Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention.
    Paul P; Gonçalves BP; Le Doare K; Lawn JE
    Curr Opin Pediatr; 2023 Apr; 35(2):223-230. PubMed ID: 36749143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.
    Schrag S; Gorwitz R; Fultz-Butts K; Schuchat A
    MMWR Recomm Rep; 2002 Aug; 51(RR-11):1-22. PubMed ID: 12211284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Seale AC; Baker CJ; Berkley JA; Madhi SA; Ordi J; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J
    Vaccine; 2019 Aug; 37(35):4877-4885. PubMed ID: 31303524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands.
    Hahn BA; de Gier B; van Kassel MN; Bijlsma MW; van Leeuwen E; Wouters MGAJ; van der Ende A; van de Beek D; Wallinga J; Hahné SJM; Jan van Hoek A
    Vaccine; 2021 May; 39(21):2876-2885. PubMed ID: 33895018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination.
    Edwards MS; Gonik B
    Vaccine; 2013 Aug; 31 Suppl 4():D66-71. PubMed ID: 23200934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B Streptococcus Colonization in Late Pregnancy and Invasive Infection in Neonates in China: A Population-Based 3-Year Study.
    Zhu Y; Huang J; Lin XZ; Chen C
    Neonatology; 2019; 115(4):301-309. PubMed ID: 30808831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.